It is with great pride and admiration that I nominate Diane Hudson, RN, OCN, for the Extraordinary Healer Award for Oncology ...

Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic ...

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 ...

Ann Foster's journey into nursing was inspired by her husband's cancer battle, leading her to pursue her childhood dream.

After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise ...

Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact ...

Enrollment and initial dosing of PAS-004 at 30 milligrams has begun in three patients with MAPK pathway-driven advanced solid ...

Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of ...

A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...